Average Co-Inventor Count = 3.05
ph-index = 18
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. G.d. Searle & Company (69 from 1,323 patents)
2. Pharmacia Corporation (6 from 200 patents)
3. Other (4 from 831,952 patents)
4. Searle & Co. (0 patent)
5. Deason, James R. (0 patent)
6. Mueller, Richard A. (0 patent)
7. Partis, Richard A. (0 patent)
79 patents:
1. 7220770 - Heterocyclo-substituted imidazoles for the treatment of inflammation
2. 7186743 - Substituted pyrazolyl compounds for the treatment of inflammation
3. 7153959 - Substituted pyrazoles as p38 kinase inhibitors
4. 7071198 - Substituted pyrazoles as p38 kinase inhibitors
5. 7019005 - 3 (5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
6. 6979686 - Substituted pyrazoles as p38 kinase inhibitors
7. 6956052 - Substituted pyrazolyl compounds for the treatment of inflammation
8. 6809083 - Use of N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections
9. 6747149 - Glucamine salts for treating hepatitis virus infections
10. 6617324 - Substituted pyrazoles as p38 kinase inhibitors
11. 6613789 - Heterocyclo-substituted imidazoles for the treatment of inflammation
12. 6579873 - 3 (5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
13. 6545021 - Use of substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
14. 6525059 - Substituted pyrazoles as p38 kinase inhibitors
15. 6515028 - Glucamine compounds for treating hepatitis virus infections